FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
Àlvaro Quintanal-Villalonga(Memorial Sloan Kettering Cancer Center), Luis Paz‐Ares(Universidad Complutense de Madrid)
Cited by 71
Related Papers
Lung cancer: current therapies and new targeted treatments
|The Lancet|2016|3.3k
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
|Journal of Hematology & Oncology|2021|92
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER
|Frontiers in Oncology|2020|51
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
|Science Translational Medicine|2023|44
Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation
|bioRxiv (Cold Spring Harbor Laboratory)|2020|24